Phosphodiesterase inhibitors: new opportunities for the treatment of asthma.
Torphy
T J
TJ
Department of Pharmacology, Smith Kline Beecham Pharmaceuticals, King of Prussia, Pennsylvania 19406.
Undem
B J
BJ
D001249:Asthma / Q000188:drug therapy* / Q000276:immunology; D006801:Humans; D007962:Leukocytes / Q000276:immunology; D009126:Muscle Relaxation / Q000187:drug effects; D010726:Phosphodiesterase Inhibitors / Q000009:adverse effects / Q000627:therapeutic use*; D012132:Respiratory Muscles / Q000187:drug effects
D010726:Phosphodiesterase Inhibitors